Fungi pathogenic to humans: Molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus

Acta Biochimica Polonica

Volumn 56, Issue 2, 2009, Pages 211-224

  Karkowska Kuleta, Justyna ^a   Rapala Kozik, Maria ^a   Kozik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Aspergillosis; Candidiasis; Cryptococcosis; Pathogenic fungi; Virulence factors

Indexed keywords

ASPERGILLUS; ASPERGILLUS FUMIGATUS; CANDIDA; CANDIDA ALBICANS; FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 68249110928     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2009_2452     Document Type: Review

References (117)

1. Presented at the XXXVI Winter School "Molecule interactions in health and disease" organized by the Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 21-26 February, 2009, Zakopane, Poland
2. Albrecht A, Felk A, Pichova I, Naglik JR, Schaller M, de Groot P, Maccallum D, Odds FC, Schäfer W, Klis F, Monod M, Hube B (2006) Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and hostpathogen interactions. J Biol Chem 281: 688-694.
3. Al-Fattani MA, Douglas LJ (2006) Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 55: 999-1008.
4. Alp S, Arikan S (2008) Investigation of extracellular elastase, acid proteinase and phospholipase activities as putative virulence factors in clinical isolates of Aspergillus species. J Basic Microbiol 48: 331-337.
5. Bader T, Bodendorfer B, Schröppel K, Morschhäuser J (2003) Calcineurin is essential for virulence in Candida albicans. Infect Immun 71: 5344-5354.
6. Bhattacharjee AK, Bennett JE, Glaudemans CP (1984) Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis 6: 619-624.
7. Blankenship JR, Wormley FL, Boyce MK, Schell WA, Filler SG, Perfect JR, Heitman J (2003) Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell 2: 422-430.
8. Bouakline A, Lacroix C, Roux N, Gangneux JP, Derouin F (2000) Fungal contamination of food in haematology units. J Clin Microbiol 38: 4272-4273.
9. Brown AJ, Gow NA (1999) Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol 7: 333-338.
10. Brown AJ, Odds FC, Gow NA (2007a) Infection-related gene expression in Candida albicans. Curr Opin Microbiol 10: 307-313.
11. Brown SM, Campbell LT, Lodge JK (2007b) Cryptococcus neoformans, a fungus under stress. Curr Opin Microbiol 10: 320-325.
12. Buchanan KL, Murphy JW (1998) What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 4: 71-83.
13. Buczyńska A, Cyprowski M, Piotrowska M, Szadkowska-Stańczyk J (2007) Indoor moulds: results of the environmental study in office rooms. Med Pr 58: 521-525 (in Polish).
14. Calderone RA, Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
15. Casadevall A, Rosas AL, Nosanchuk JD (2000) Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 3: 354-358.
16. Casanova M, Lopez-Ribot JL, Monteagudo C, Llombart-Bosch A, Sentandreu R, Martinez JP (1992) Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect Immun 60: 4221-4229.
17. Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP (1998) Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 62: 130-180.
18. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
19. Chang YC, Penoyer LA, Kwon-Chung KJ (1996) The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Inf Immun 64: 1977-1983.
20. Chang YC, Kwon-Chung KJ (1994) Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol 14: 4912-4919.
21. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, Paul-Satyaseela M, Kim KS, Kwon-Chung KJ (2004) Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the bloodbrain barrier. Infect Immun 72: 4985-4995.
22. Charlier C, Chrétien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F (2005) Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166: 412-432.
23. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F (2009) Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77: 120-127.
24. Chaskes S, Tyndall RL (1975) Pigment production by Cryptococcus neoformans from para-and ortho-diphenols: effect of the nitrogen source. J Clin Microbiol 1: 509-514.
25. Chaturvedi V, Wong B, Newman SL (1996a) Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates. J Immunol 156: 3836-3840.
26. Chaturvedi V, Flynn T, Niehaus WG, Wong B (1996b) Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans. Microbiology 142: 937-943.
27. Chen SC, Wright LC, Golding JC, Sorrell TC (2000) Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J 347: 431-439.
28. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y, Kim KS, Suzuki K, Jong AY (2003) Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52: 961-970.
29. Clancy CJ, Nguyen MH (1998) Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 114: 629-634.
30. Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, Perfect JR (2001) Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 39: 166-175.
31. Crowe JD, Sievwright IK, Auld GC, Moore NR, Gow NA, Booth NA (2003) Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol Microbiol 47: 1637-1651.
32. dos Santos AL, de Carvalho IM, da Silva BA, Portela MB, Alviano CS, de Araújo Soares RM (2006) Secretion of serine peptidase by a clinical strain of Candida albicans: influence of growth conditions and cleavage of human serum proteins and extracellular matrix components. FEMS Immunol Med Microbiol 46: 209-220.
33. Eckert SE, Sheth CC, Mühlschlegel FA (2007) Regulation of morphogenesis in Candida species. In Candida. Comparative and functional genomics. d'Enfert Ch, Hube B, eds, pp 263-291. Caister Academic Press, Norfolk.
34. d'Enfert C, Hube B (2007) Introduction. In Candida. Comparative and functional genomics. d'Enfert Ch, Hube B, eds, pp 1-5. Caister Academic Press, Norfolk.
35. Espinel-Ingroff A (2008) Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol 25: 101-106.
36. Filler SG (2006) Candida-host cell receptor-ligand interactions. Curr Opin Microbiol 9: 333-339.
37. Filler SG, Sheppard DC, Edwards JE Jr (2006) Molecular basis of fungal adherence to endothelial and epithelial cells. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 187-196. ASM Press, Washington DC.
38. Ganendren R, Carter E, Sorrell T, Widmer F, Wright L (2006) Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line. Microbes Infect 8: 1006-1015.
39. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13: 122-143.
40. Gniadek A, Macura AB (2007) Intensive care unit environment contamination with fungi. Adv Med Sci 52: 283-287.
41. Guerrero A, Fries BC (2008) Phenotypic switching in Cryptococcus neofromans contributes to virulence by changing the immunological host response. Inf Immun 76: 4322-4331.
42. Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, Robertson VJ, Musvaire P, Mason PR (2000) Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 14: 1401-1407.
43. Hinrikson HP, Hurst SF, De Aguirre L, Morrison CJ (2005) Molecular methods for the identification of Aspergillus species. Med Mycol 43: S129-S137.
44. Hogan LH, Klein BS, Levitz SM (1996) Virulence factors of medically important fungi. Clin Microbiol Rev 9: 469-488.
45. Hube B, Naglik J (2001) Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147: 1997-2005.
46. Husain S, Wagener MM, Singh N (2001) Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 7: 375-381.
47. Ibrahim AS, Mirbod F, Filler SG, Banno Y, Cole GT, Kitajima Y, Edwards JE Jr, Nozawa Y, Ghannoum MA (1995) Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63: 1993-1998.
48. Jong AY, Stins MF, Huang SH, Chen SH, Kim KS (2001) Traversal of Candida albicans across human blood-brain barrier in vitro. Infect Immun 69: 4536-4544.
49. Jung WH, Kronstad JW (2008) Iron and fungal pathogenesis: a case study with Cryptococcus neoformans. Cell Microbiol 10: 277-284.
50. Lamy B, Moutaouakil M, Latgé JP, Davies J (1991) Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol 5: 1811-1815.
51. Latgé JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12: 310-350.
52. Latgé JP (2001) The pathobiology of Aspergillus fumigatus. Trends Microbiol 9: 382-389.
53. Lengeler KB, Davidson RC, D'souza C, Harashima T, Shen WC, Wang P, Pan X, Waugh M, Heitman J (2000) Signal transduction cascades regulating fungal development and virulence. Microbiol Mol Biol Rev 64: 746-785.
54. Liappis AP, Kan VL, Richman NC, Yoon B, Wong B, Simon GL (2008) Mannitol and inflammatory markers in the cerebral spinal fluid of HIV-infected patients with cryptococcal meningitis. Eur J Clin Microbiol Infect Dis 27: 477-479.
55. Lin X, Heitman J (2005) Chlamydospore formation during hyphal growth in Cryptococcus neoformans. Eukaryot Cell 4: 1746-1754.
56. Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
57. Macura AB, Pawlik B, Szczepko I (2000) The susceptibility of Aspergillus and Penicillium to recent antimycotics. Wiad Parazytol 46: 157-162 (in Polish).
58. Mavor AL, Thewes S, Hube B (2005) Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 6: 863-874.
59. McFadden DC, Fries BC, Wang F, Casadevall A (2007) Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans. Eukaryot Cell 6: 1464-1473.
60. Mendes A, Mores AU, Carvalho AP, Rosa RT, Samaranayake LP, Rosa EA (2007) Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells. Biol Pharm Bull 30: 1813-1815.
61. Mitchell TG, Perfect JR (1995) Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8: 515-548.
62. Moutaouakil M, Monod M, Prévost MC, Bouchara JP, Paris S, Latgé JP (1993) Identification of the 33-kDa alkaline protease of Aspergillus fumigatus in vitro and in vivo. J Med Microbiol 39: 393-399.
63. Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 67: 400-428.
64. Naglik JR, Albrecht A, Bader O, Hube B (2004) Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6: 915-926.
65. Newport G, Agabian N (1997) KEX2 influences Candida albicans proteinase secretion and hyphal formation. J Biol Chem 272: 28954-28961.
66. Noverr MC, Cox GM, Perfect JR, Huffnagle GB (2003) Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun 71: 1538-1547.
67. OBrian GR, Fakhoury AM, Payne GA (2003) Identification of genes differentially expressed during aflatoxin biosynthesis in Aspergillus flavus and Aspergillus parasiticus. Fungal Genet Biol 39: 118-127.
68. Odds FC, Gow NAR, Brown AJP (2006) Toward a molecular understanding of Candida albicans virulence. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 305-319. ASM Press, Washington DC.
69. Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, Heitman J (1997) Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 16: 2576-2589.
70. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB (2004) Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 164: 1761-1771.
71. Paris S, Wysong D, Debeaupuis JP, Shibuya K, Philippe B, Diamond RD, Latgé JP (2003) Catalases of Aspergillus fumigatus. Infect Immun 71: 3551-3562.
72. Pawlik B, Szul A, Macura AB (2006) Susceptibility of fungi isolated from clinical materials to voriconazole. Med Dosw Mikrobiol 58: 155-161 (in Polish).
73. Perfect JR, Rude TH, Wong B, Flynn T, Chaturvedi V, Niehaus W (1996) Identification of a Cryptococcus neoformans gene that directs expression of the cryptic Saccharomyces cerevisiae mannitol dehydrogenase gene. J Bacteriol 178: 5257-5262.
74. Perfect JR, Casadevall A (2002) Cryptococcosis. Infect Dis Clin North Am 16: 837-874.
75. Perfect JR, Casadevall A (2006) Fungal molecular pathogenesis: what can it do and why do we need it? In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 3-11. ASM Press, Washington DC.
76. Perfect JR (2006) Cryptococcus neofromans: a sugar-coated killer. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 281-303. ASM Press, Washington DC.
77. Phan QT, Fratti RA, Prasadarao NV, Edwards JE Jr, Filler SG (2005) N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J Biol Chem 280: 10455-10461.
78. Pinti M, Orsi CF, Gibellini L, Esposito R, Cossarizza A, Blasi E, Peppoloni S, Mussini C (2007) Identification and characterization of an aspartyl protease from Cryptococcus neoformans. FEBS Lett 581: 3882-3886.
79. Plonka PL, Grabacka M (2006) Melanin synthesis in microorganisms-biotechnological and medical aspects. Acta Biochim Polon 53: 429-443.
80. Polacheck I, Hearing VJ, Kwon-Chung KJ (1982) Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacteriol 150: 1212-1220.
81. Polacheck I, Kwon-Chung KJ (1988) Melanogenesis in Cryptococcus neoformans. J Gen Microbiol 134: 1037-1041.
82. Ramage G, Ghannoum MA, Lopez-Ribot JL (2006) Fungal biofilms: agents of disease and drug resistance. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 177-185. ASM Press, Washington D.C
83. Rapala-Kozik M, Karkowska J, Jacher A, Golda A, Barbasz A, Guevara-Lora I, Kozik A (2008) Kininogen adsorption to the cell surface of Candida spp. Int Immunopharmacol 8: 211-216.
84. Reese AJ, Doering TL (2003) Cell wall α-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol Microbiol 50: 1401-1409.
85. Rementeria A, López-Molina N, Ludwig A, Vivanco AB, Bikandi J, Pontón J, Garaizar J (2005) Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 22: 1-23.
86. Ren P, Jankun TM, Belanger K, Bracken MB, Leaderer BP (2001) The relation between fungal propagules in indoor air and home characteristics. Allergy 56: 419-424.
87. Rhodes JC, Brakhage AA (2006) Molecular determinants of virulence in Aspergillus fumigatus. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 333-345. ASM Press, Washington DC.
88. Richardson MD (2005) Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 56: 5-11.
89. Ruiz-Herrera J, Elorza MV, Valentín E, Sentandreu R (2006) Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res 6: 14-29.
90. Sanglard D, White TC (2006) Molecular principles of antifungal drug resistance. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 197-212. ASM Press, Washington D.C
91. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L (2004) Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 72: 2229-2239.
92. Schaller M, Borelli C, Korting HC, Hube B (2005) Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48: 365-377.
93. Sheppard DC, Yeaman MR, Welch WH, Phan QT, Fu Y, Ibrahim AS, Filler SG, Zhang M, Waring AJ, Edwards JE Jr (2004) Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem 279: 30480-30489.
94. Sia RA, Lengeler KB, Heitman J (2000) Diploid strains of the pathogenic basidiomycete Cryptococcus neoformans are thermally dimorphic. Fungal Genet Biol 29: 153-163.
95. Siafakas AR, Sorrell TC, Wright LC, Wilson C, Larsen M, Boadle R, Williamson PR, Djordjevic JT (2007) Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J Biol Chem 282: 37508-37514.
96. Singleton DR, Masuoka J, Hazen KC (2001) Cloning and analysis of a Candida albicans gene that affects cell surface hydrophobicity. J Bacteriol 183: 3582-3588.
97. Slutsky B, Buffo J, Soll DR (1985) High-frequency switching of colony morphology in Candida albicans. Science 230: 666-669.
98. Slutsky B, Staebell M, Anderson J, Risen L, Pfaller M, Soll DR (1987) "White-opaque transition": a second highfrequency switching system in Candida albicans. J Bacteriol 169: 189-197.
99. Staab JF, Bradway SD, Fidel PL, Sundstrom P (1999) Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283: 1535-1538.
100. Steinbach WJ, Cramer RA Jr, Perfect BZ, Asfaw YG, Sauer TC, Najvar LK, Kirkpatrick WR, Patterson TF, Benjamin DK Jr, Heitman J, Perfect JR (2006) Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryot Cell 5: 1091-1103.
101. Subramanian S, Mathai D (2005) Clinical manifestations and management of cryptococcal infection. J Postgrad Med 51: S21-S26.
102. Tekaia F, Latgé JP (2005) Aspergillus fumigatus: saprophyte or pathogen? Curr Opin Microbiol 8: 385-392
103. Theiss S, Ishdorj G, Brenot A, Kretschmar M, Lan CY, Nichterlein T, Hacker J, Nigam S, Agabian N, Köhler GA (2006) Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence. Int J Med Microbiol 296: 405-420.
104. Todaro-Luck F, Reiss E, Cherniak R, Kaufman L (1989) Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect Immun 57: 3882-3887.
105. Tomee JFC, Kauffman HF (2000) Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy 30: 476-484.
106. Torres-Guererro H, Edman JC (1994) Melanin-deficient mutants of Cryptococcus neoformans. J Med Vet Mycol 32: 303-313.
107. Tsai HF, Wheeler MH, Chang YC, Kwon-Chung KJ (1999) A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus. J Bacteriol 181: 6469-6477.
108. Warris A, Klaassen CH, Meis JF, De Ruiter MT, De Valk HA, Abrahamsen TG, Gaustad P, Verweij PE (2003) Molecular epidemiology of Aspergillus fumigatus iso lates recovered from water, air, and patients shows two clusters of genetically distinct strains. J Clin Microbiol 41: 4101-4106.
109. Weissman Z, Kornitzer D (2004) A family of Candida cell surface haem-binding proteins involved in haemin and haemoglobin-iron utilization. Mol Microbiol 53: 1209-1220.
110. White TC, Agabian N (1995) Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 177: 5215-5221.
111. White TC, Marr KA, Bowden RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11: 382-402.
112. Whiteway M, Bachewich C (2006) Signal transduction in the interactions of fungal pathogens and mammalian hosts. In Molecular principles of fungal pathogenesis. Heitman J, Filler SG, Edwards JE Jr, Mitchell AP, eds, pp 143-161. ASM Press, Washington DC.
113. Wickes BL, Mayorga ME, Edman U, Edman JC (1996) Dimorphism and haploid fruiting in Cryptococcus neoformans: association with the alpha-mating type. Proc Natl Acad Sci USA 93: 7327-7331.
114. Williamson PR (1994) Biochemical and molecular characterization of the diphenol oxidase of Cryptococcus neoformans: identification as a laccase. J Bacteriol 176: 656-664.
115. Wong B, Perfect JR, Beggs S, Wright KA (1990) Production of the hexitol d-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect Immun 58: 1664-1670.
116. Yang YL (2003) Virulence factors of Candida species. J Microbiol Immunol Infect 36: 223-228.
117. Zhu X, Williamson PR (2004) Role of laccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res 5: 1-10.